- £2.26m
- £1.68m
- £3.44m
- 75
- 93
- 66
- 93
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5.22 | 4.44 | 3.29 | 3.57 | 3.44 |
Cost of Revenue | |||||
Gross Profit | 2.5 | 2.19 | 1.52 | 1.63 | 1.83 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5.17 | 4.43 | 3.1 | 4.15 | 3.13 |
Operating Profit | 0.044 | 0.003 | 0.189 | -0.578 | 0.303 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.042 | 0.005 | 0.19 | -0.578 | 0.305 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.001 | -0.016 | 0.088 | -0.631 | 0.243 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.001 | -0.016 | 0.088 | -0.631 | 0.243 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.001 | -0.016 | 0.088 | -0.631 | 0.243 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.009 | 0.008 | 0.002 | -0.01 | 0.021 |
Dividends per Share |